Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer von Feliu, J, Safont, M J, Salud, A, Losa, F, García-Girón, C, Bosch, C, Escudero, P, López, R, Madroñal, C, Bolaños, M, Gil, M, Llombart, A, Castro-Carpeño, J, González-Barón, M

Volltext

A critical role for choline kinase-α in the aggressiveness of bladder carcinomas von Hernando, E, Sarmentero-Estrada, J, Koppie, T, Belda-Iniesta, C, Ramírez de Molina, V, Cejas, P, Ozu, C, Le, C, Sánchez, J J, González-Barón, M, Koutcher, J, Cordón-Cardó, C, Bochner, B H, Lacal, J C, Ramírez de Molina, A

Volltext

Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer von Feliu, J, Borrega, P, León, A, López-Gómez, L, López, M, Castro, J, Belda-Iniesta, C, Barriuso, J, Martínez, V, González-Barón, M

Volltext

UFT (tegafur–uracil) in rectal cancer von Casado, E., Pfeiffer, P., Feliu, J., González-Barón, M., Vestermark, L., Jensen, H.A.

Volltext

Immunohistochemical analysis of tumour regression grade for rectal cancer after neoadjuvant chemoradiotherapy von García, V. Moreno, Batlle, J. F., Casado, E., Burgos, E., de Castro, J., Belda, C., Barriuso, J., Sánchez, J. J., García-Cabezas, M. Á., González-Barón, M., Cejas, P.

Volltext

Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy von Moreno García, V, Cejas, P, Blanco Codesido, M, Feliu Batlle, J, de Castro Carpeño, J, Belda-Iniesta, C, Barriuso, J, Sánchez, J. J, Larrauri, J, González-Barón, M, Casado, E

Volltext

Oxycodone: a pharmacological and clinical review von Ordóñez Gallego, A., González Barón, M., Espinosa Arranz, E.

Volltext

Breast Cancer Prognosis Determined by Gene Expression Profiling: A Quantitative Reverse Transcriptase Polymerase Chain Reaction Study von Espinosa, E., Vara, J.A. Fresno, Redondo, A., Sánchez, J.J., Hardisson, D., Zamora, P., Pastrana, F. Gómez, Cejas, P., Martínez, B., Suárez, A., Calero, F., Barón, M. González

Volltext

Phospholipid Hydroperoxide Glutathione Peroxidase (PHGPx) expression is downregulated in poorly differentiated breast invasive ductal carcinoma von Cejas, P., García-Cabezas, M. A., Casado, E., Belda-Iniesta, C., De Castro, J., Fresno, J. A., Sereno, M., Barriuso, J., Espinosa, E., Zamora, P., Feliu, J., Redondo, A., Hardisson, D. A., Renart, J., González-Barón, M.

Volltext

Neoadjuvant therapy of rectal carcinoma with UFT–leucovorin plus radiotherapy von Feliu, J., Calvillo, J., Escribano, A., de Castro, J., Sánchez, M. E., Mata, A., Espinosa, E., García Grande, A., Mateo, A., González Barón, M.

Volltext

Efficacy, tolerability and management of raltitrexed (Tomudex™) monotherapy in patients with advanced colorectal cancer: a review of phase II/III trials von Cunningham, D., Zalcberg, J., Maroun, J., James, R., Clarke, S., Maughan, T.S., Vincent, M., Schulz, J., González Barón, M., Facchini, T.

Volltext

Descriptive analysis of clinical factors affecting terminally ill cancer patients von Jiménez-Gordo, A. M., Feliu, J., Martínez, B., de-Castro, J., Rodríguez-Salas, N., Sastre, N., Vilches, Y., Espinosa, E., Rodríguez-Aizcorbe, J. R., González-Barón, M.

Volltext

Irinotecan plus raltitrexed as first-line treatment in advanced colorectal cancer: a phase II study von Feliu, J, Salud, A, Escudero, P, López-Gómez, L, Pericay, C, Castañón, C, de Tejada, M R López, Rodríguez-García, J M, Martínez, M P, Martín, M Sanz, Sánchez, J J, Barón, M González

Volltext

Phase II study of a fixed dose-rate infusion of gemcitabine associated with docetaxel in advanced non-small-cell lung carcinoma von DE CASTRO, J, LORENZO, A, GONZALEZ BARON, M, MORALES, S, BELON, J, DORTA, J, LIZON, J, MADRONAL, C, GALLURT, P. M, CASADO, E, FELIU, J

Volltext

Irinotecan-Cetuximab-Bevacizumab as a Salvage Treatment in Heavily Pretreated Metastatic Colorectal Cancer Patients: A Retrospective Observational Study von Feliu Batlle, J., Cuadrado, E., Castro, J., Caldés, T., Belda, C., Sastre, J., Barriuso, J., Martínez Marín, V., Díaz-Rubio, E., González-Barón, M.

Volltext

Docetaxel and high-dose epirubicin as neoadjuvant chemotherapy in locally advanced breast cancer von ESPINOSA, E, MORALES, S, JANARIZ, J, DE LA PUENTE, M, CHECA, T, MEL, J. R, GONZALEZ BARON, M, BORREGA, P, CASAS, A, MADRONAL, C, MACHENGS, I, ILLARRAMENDI, J. A, LIZON, J, MORENO, J. A, BELON, J

Volltext

Fixed dose-rate infusion of gemcitabine in combination with cisplatin and UFT in advanced carcinoma of the pancreas von FELIU, J, GARCIA SAENZ, J, LEON, A, GONZALEZ BARON, M, RODRIGUEZ JARAIZ, A, CASTANON, C, CRUZ, M, FONSECA, E, LOMAS, M, CASTRO, J, JARA, C, CASADO, E

Volltext

Phase II study of a fixed dose-rate infusion of gemcitabine associated with uracil/tegafur in advanced carcinoma of the pancreas von Feliu, J., Mel, R., Borrega, P., López Gómez, L., Escudero, P., Dorta, J., Castro, J., Vázquez-Estévez, S. E., Bolaños, M., Espinosa, E., González Barón, M.

Volltext

New screening method for lung cancer by detecting volatile organic compounds in breath von Belda-Iniesta, C, de Castro Carpeño, J, Carrasco, J A, Moreno, V, Casado Sáenz, E, Feliu, J, Sereno, M, García Río, F, Barriuso, J, González Barón, M

Volltext

Oxycodone: a pharmacological and clinical review von Ordóñez Gallego, A, González Barón, M, Espinosa Arranz, E

Volltext